What tests should be ordered for a comprehensive sexually transmitted infection (STI) screen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Comprehensive STI Screening Tests

For a comprehensive sexually transmitted infection screen, order nucleic acid amplification tests (NAATs) for Chlamydia trachomatis and Neisseria gonorrhoeae from appropriate anatomical sites, serologic testing for syphilis (treponemal-specific test followed by RPR), HIV screening, and hepatitis B surface antigen testing, with additional tests for Trichomonas vaginalis in women and consideration of extragenital site testing in high-risk populations. 1

Core Testing Panel

The essential components of comprehensive STI screening include:

Bacterial Infections

  • Chlamydia and Gonorrhea: NAATs are the preferred testing method due to superior sensitivity compared to culture 2, 3, 1. These tests can be performed on:
    • Women: Vaginal swabs (preferred), cervical swabs, or first-void urine 2, 1
    • Men: First-void urine or urethral swabs 2, 1
    • High-risk individuals (especially MSM): Add rectal and pharyngeal specimens 1, 4, 1

The evidence strongly supports simultaneous testing for both Chlamydia and gonorrhea, as co-infection is common 3, 1. Testing all three sites (genital, rectal, oral) in appropriate populations increases detection rates significantly—from 10.1% to 13.8% in one study 5.

Syphilis

  • Use the reverse screening algorithm: treponemal-specific test first (EIA/chemiluminescence immunoassay), followed by nontreponemal test (RPR or VDRL) for confirmation 1
  • This approach is now standard in most laboratories and provides better sensitivity than traditional RPR-first screening 1

HIV

  • Screen all sexually active patients aged 13-64 years regardless of risk factors 1, 4, 1
  • Use fourth-generation antigen/antibody combination tests when available
  • Repeat screening at least annually for sexually active individuals, more frequently (every 3-6 months) for those with multiple partners, history of STIs, or other high-risk behaviors 4

Hepatitis B

  • Test for hepatitis B surface antigen (HBsAg) 6, 7
  • Vaccinate if negative 2, 6

Additional Testing Based on Clinical Context

For Women

  • Trichomonas vaginalis: NAAT from vaginal specimen is preferred over wet mount due to superior sensitivity 2, 1
  • Simultaneous testing for Chlamydia, gonorrhea, and Trichomonas is optimal for detecting the most common treatable STIs 1

For Patients with Genital Lesions

  • Serologic test for syphilis
  • Diagnostic tests for herpes simplex virus (culture, DFA, or NAAT from lesion)
  • HIV screening (inflammatory epithelium enhances HIV transmission risk) 1

For High-Risk Populations

Men who have sex with men require extragenital testing:

  • Rectal swabs for Chlamydia and gonorrhea culture/NAAT 1, 4, 1
  • Pharyngeal swabs for gonorrhea culture 1, 4, 1
  • Consider hepatitis C screening (sexual transmission documented in MSM) 1

Special Population Considerations

Pregnant Women

Mandatory screening includes 6, 1, 7, 1:

  • Syphilis serology at first prenatal visit (repeat in third trimester and at delivery for high-risk patients)
  • Hepatitis B surface antigen at first prenatal visit
  • HIV at first prenatal visit AND third trimester
  • Gonorrhea and Chlamydia for women <25 years or those at increased risk
  • Group B Streptococcus at 35-37 weeks (vaginal and rectal swabs)

Sexual Assault Victims

Initial testing should include 2, 6:

  • NAATs for gonorrhea and Chlamydia from all sites of penetration
  • Wet mount and NAAT for Trichomonas
  • Baseline serology for syphilis, HIV, and hepatitis B
  • Follow-up testing at 2 weeks, then serologic tests at 6,12, and 24 weeks

Screening Frequency

  • Sexually active individuals: At least annually 4
  • High-risk patients (multiple/anonymous partners, prior STI history, MSM): Every 3-6 months 4
  • After new risk exposure: Rescreen when sexual history reveals new or persistent risk factors 8

Critical Pitfalls to Avoid

  1. Don't rely on symptoms alone: 25-40% of genital infections remain unidentified despite testing, and most infections are acquired from asymptomatic partners 1

  2. Don't skip extragenital testing in MSM: Limiting testing to urogenital sites misses significant infections 1, 4, 1

  3. Don't use quinolones for gonorrhea empirically: Resistance is widespread, particularly in MSM and in California/Hawaii 3

  4. Don't forget partner notification: Treatment failure is usually reinfection from untreated partners 1

  5. Don't assume negative NAAT means no co-infection: If Chlamydia testing is unavailable or non-NAAT was used, treat empirically for both gonorrhea and Chlamydia 3

Emerging Considerations

  • Mycoplasma genitalium: Increasingly recognized as causing urethritis in males and cervicitis/PID in females, though routine screening is not yet standard 1
  • Antimicrobial resistance in N. gonorrhoeae: Monitor local resistance patterns and adjust treatment accordingly 3, 1

References

3
Guideline

sexually transmitted diseases treatment guidelines, 2006.

MMWR Recommendations and Reports, 2006

Related Questions

Which laboratory tests should be ordered for a patient being evaluated for sexually transmitted infection (STI)?
Which screening tests should be performed for sexually transmitted infections in sexually active adults?
What screenings are most appropriate for a 23-year-old cisgender female with HIV (Human Immunodeficiency Virus) on Antiretroviral Therapy (ART) with a stable CD4 (Cluster of Differentiation 4) count and undetectable HIV RNA, who reports two new sexual partners since her last clinic visit?
Can reliable STI screening be performed during a patient's menstrual period?
What are the standard procedures and ICD-10 (International Classification of Diseases, 10th Revision) codes for a patient undergoing a sexually transmitted disease (STD) check, including tests for chlamydia, gonorrhea, syphilis, and Human Immunodeficiency Virus (HIV)?
Could a 45-year-old obese male, 2 weeks post percutaneous transluminal coronary angioplasty (PTCA) of the left anterior descending artery, presenting with severe hypertension, tachycardia, exertional shortness of breath that improves with non‑invasive ventilation, normal arterial blood gases at rest, preserved left‑ventricular ejection fraction, no peripheral edema, and normal renal function, be diagnosed with obesity‑hypoventilation syndrome?
What is the recommended starting dose of Depakote ER (divalproex sodium extended‑release)?
What does a curvilinear lucency with sclerotic margins at the lateral aspect of the tip of the first distal phalanx on a foot X‑ray indicate—vascular channel or undisplaced fracture?
For a 200‑lb (≈91 kg) patient, what starting dose of Depakote ER (valproic acid extended‑release) should be used?
What is the recommended treatment for dry skin on the ball of the foot?
What is the recommended treatment for an adult patient with elevated lipoprotein(a) (>50 mg/dL) who has been optimized on high‑intensity statin therapy and standard cardiovascular risk factors have been addressed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.